Advertisement

Topics

Companies Related to "Innovating trusted class antibiotics attack superbugs" [Most Relevant Company Matches] RSS

16:17 EDT 22nd April 2018 | BioPortfolio

Here are the most relevant search results for "Innovating trusted class antibiotics attack superbugs" found in our extensive corporate database of over 50,000 company records.

Showing "Innovating trusted class antibiotics attack superbugs" Companies 1–25 of 2,000+

Relevant

Enanta Pharmaceuticals

Enanta Pharmaceuticals is a research and development company that uses its novel chemistry approach and drug discovery capabilities to create best in class small molecule drugs in the infectious disease field. Enanta is developing novel protease, NS5A, polymerase, and cyclophilin-based inhibitors targeted against the Hepatitis C virus (HCV). Additionally, the Company has created a new class of m...


Destiny Pharma Ltd

Destiny Pharma is a UK based anti-infectives pharmaceutical company founded, in 1997, by pharma industry executives. The company has developed and patented a portfolio of novel drugs that have a completely different mode of action from conventional antibiotics. These compounds (codenamed XF Drugs) have been shown to work in such a way that minimizes the development of bacterial resistance to repea...

Peptilogics

Peptilogics is an early-stage biotechnology company developing a new class of antibiotics with a novel mechanism of action derived from their eCAP (engineered cationic antibiotic peptide) platform for the treatment of multidrug-resistant infections. Through rational design, this technology dramatically amplifies the antimicrobial activity of naturally-occu...


9-11Research

9-11 Research is an ongoing effort to discover the truth about the attacks on New York City and Washington, D.C. on September 11th, 2001. To that end we provide a growing hypertext documentary of the attack and its aftermath, easily browsed archives of evidence, and a body of original analysis based on that evidence. We maintain the website as a public service. 9-11 Research critically examines th...

Novexel

Novexel is a speciality pharmaceutical company focused on the discovery and development of novel antibiotics designed to overcome the significant global problem of microbial resistance. The ever increasing resistance to marketed antibiotics has led to a clear need for

Duran Wheaton Kimble

DURAN WHEATON KIMBLE provides the world’s laboratories with the most comprehensive range of premium labware in the field of scientific and technical applications. We are constantly innovating our premium lab glassware, specialty products, and service offerings to support the life science and pharmaceutical industries. We are the trusted manufacturing ...

Protez Pharmaceuticals

Protez Pharmaceuticals develops new antibiotics to combat the growing problem of drug resistance, as well as agents that improve the efficacy of current antibiotics.Our focus is difficult-to-treat hospital-based infections. In the United States alone, over eight million people are hospitalized with bacterial infections each year, accounting for greater then 90 million days of therapy. Many of thes...

HANFORD PHARMACEUTICALS

In hospitals across America, physicians manage the risks of infection with a wide range of antibiotics at their disposal.Many of these antimicrobials remain patent-protected and available only from their innovators. But a greater number of still-valuable agents are off-patent or licensed for supply from additional producers.Hanford Pharmaceuticals, founded in 1846 in Upstate New York and still pri...

NCS Technologies

"Innovating." "Solutions."These two words have described NCS Technologies throughout our over two decades of experience.Solving problems in corporate systems environments. Creating solutions for business challenges through hundreds of successful projects. Innovating the effective use of technology for some of the world’s leading businesses.AT&T. Aventis. AT&T Wireless. Bayer. Bristol-Myers ...

Amphora Discovery Corporation

Amphora is a fully integrated drug discovery and development company. The company employs cutting-edge chemogenomic, systems biology and microfluidics technologies to develop innovative, targeted therapies for significant human diseases. Our primary mission is to improve patient care by rapidly developing proprietary human therapeutics that target the complex molecular causes of disease and to p...

Cardiac and Stroke Network

The Cardiac and Stroke Network is a collaboration of hospitals, emergency room service providers and community stakeholders in four north Puget Sound counties (Island, San Juan, Skagit and Snohomish) who have developed streamlined processes to ensure that heart attack and stroke patients get the best coordinated care within the shortest amount of time, ...

Jingxin Pharmaceutical Co., Ltd.

We take the lead in approving cGMP and ISO14001certification in China and have established Postdoctoral Scientific Research Working Station. With a contingent of first-class professional personnel, steady and practical management team, advanced technology, high quality products and extensive marketing network we have become into the biggest manufacturer of Fluoroquinolones antibiotics and also bec...

Enanta Pharmaceuticals, Inc.

Enanta Phatmaceuticals ARE A RESEARCH AND DEVELOPMENT-FOCUSED BIOTECHNOLOGY COMPANY that uses its robust chemistry-driven approach and drug discovery capabilities to create small molecule drugs in the infectious disease field. Enanta are discovering and developing novel inhibitors designed for use against the hepatitis C virus, or HCV. These inhibitors include members of the direct acting antivi...

Athelas SA

Athelas is a drug discovery company developing a novel class of drugs to treat bacterial infectious diseases. Contrary to conventional antibiotics, Athelas’ drugs treat bacterial infections by targeting mechanisms that are essential for bacterial colonization, invasion and survival only when bacteria are within the host’ environment. "

IntraBiotics Pharmaceuticals Incorporated

The mission of IntraBiotics is to develop and commercialize novel antibacterial and antifungal drugs for the prevention or treatment of serious infectious diseases. IntraBiotics has developed two new antibiotics, Ramoplanin Oral and Protegrin IB-367 Rinse, to the third stage of clinical trials. Ramoplanin Oral and Protegrin IB-367 Rinse are both new types of antibiotics that may address major medi...

Affinium Pharmaceuticals

Affinium Pharmaceuticals is a specialty pharmaceutical company focused on the discovery, development and commercialization of novel anti-infective medicines. AFN-1252 utilizes a unique mechanism of action by directly inhibiting the function of the bacterial fatty acid synthesis (FAS) II pathway. Affinium’s FASII antibacterial programs constitute a new antibiotic franchise with the potential for...

Auspherix Limited

Auspherix Ltd has discovered a brand new class of antibacterials with a unique profile and novel mechanism of action that could overcome rising problems of resistance to current antibiotics. Its compound series show activity against a broad range of multidrug resistant (MDR) important Gram-negative and Gram-positive bacterial, with PK profiles consistent w...

Harbinger Medical Inc.

Harbinger markets a non-invasive cardiac diagnostic tool that helps physicians more accurately assess a patient's risk of life threatening arrhythmias. Harbinger aids the physician's decision regarding treatment options, which range from lifestyle changes to anti-arrhythmic medication to the implantation of a defibrillator. Our first target market includes 350,000 people each year who suffer a hea...

Response Biomedical Corp

Response Biomedical is commercializing a new class of diagnostic with the world's only immunoassay platform that provides lab quality information in a matter of minutes, anywhere, every time. RAMP® tests are commercially available for three cardiac markers used in the early detection of heart attack, environmental detection of West Nile virus, and biodefense applications including the detection o...

Auspherix Limited (UK)

Auspherix Ltd has discovered a brand new class of antibacterials with a unique profile and novel mechanism of action that could overcome rising problems of resistance to current antibiotics. Its compound series show activity against a broad range of multidrug resistant (MDR) important Gram-negative and Gram-positive bacterial infections, with profiles cons...

TYRX, Inc.

TYRX, Inc. commercializes innovative, implantable combination drug/device products focused on infection control including the AIGISRx® Antibacterial Envelope and AIGISRx® FS products. AIGISRx products contain antimicrobial agents, rifampin and minocycline, which have been shown to reduce infection by organisms representing a majority of the infection...

Ingenico Group

Ingenico Group (Euronext: FR0000125346 - ING) is the global leader in seamless payment, providing smart, trusted and secure solutions to empower commerce across all channels, in-store, online and mobile. With the world’s largest payment acceptance network, we deliver secure payment solutions with a local, national and international scope. We are the t...

Trusted Quote

A leading national broker for insurance products, Trusted Quote brings consumers term life insurance quotes as well as quotes from top providers in dental, vision, and long term care insurance. Located in Roseville, California, Trusted Quote is a national division of Pinney Insurance Center, Inc.

NanoViricides, Inc.

NanoViricides, Inc. (www.nanoviricides.com) is a development stage company that is creating special purpose nanomaterials for viral therapy. The Company's novel nanoviricide™ class of drug candidates are designed to specifically attack enveloped virus particles and to dismantle them. The Company is developing drugs against a number of viral dis...

PLANTON GmbH

Infectious diseases are the most frequent causes of death. Microbial resistance to antibiotics is an increasing problem in medical treatment and thus an important focus in pharmaceutical research. PLANTON develops and produces a novel class of antiinfectiva – antimicrobial peptides. These molecules have a strong antibiotic efficacy and a special mechanism avoiding resistance of human pathogens. ...


More From BioPortfolio on "Innovating trusted class antibiotics attack superbugs"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks